NBCL Pharmaceuticals Private Limited
About NBCL Pharmaceuticals Private Limited
Data last updated:
NBCL Pharmaceuticals Private Limited was a private limited company based in Nagpur, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 10 August 2016.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2016PTC284668.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Chandir Chimandas Ramani and Babita Chandir Ramani.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at House No. 91 Besides Nikalas Mandir Bhaji Mandi, Nagpur, Maharashtra, India – 440002.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. 91 Besides Nikalas Mandir Bhaji Mandi, Nagpur, Maharashtra, India – 440002
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of NBCL Pharmaceuticals Private Limited FY 2019 filings available
Financial Statement Summary of NBCL Pharmaceuticals Private Limited
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of NBCL Pharmaceuticals Private Limited
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of NBCL Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of NBCL Pharmaceuticals Private Limited
NBCL Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandir Chimandas Ramani Also directs: BBCL Pharmaceuticals Private Limited | Director | 18 Nov 2016 | 9 Years 11 Months | As last reported |
| Babita Chandir Ramani Also directs: BBCL Pharmaceuticals Private Limited | Director | 18 Nov 2016 | 9 Years 11 Months | As last reported |
Auditor Details of NBCL Pharmaceuticals Private Limited
NBCL Pharmaceuticals Private Limited is audited by SUSHILCHANDWANI&CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUSHILCHANDWANI&CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of NBCL Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of NBCL Pharmaceuticals Private Limited
NBCL Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at NBCL Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to NBCL Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on NBCL Pharmaceuticals Private Limited
NBCL Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Ritesh Chimandas Ramani ceased to be Director on 21 Nov 2016.
Credit Ratings, Litigation & Regulatory Alerts for NBCL Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by NBCL Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of NBCL Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of NBCL Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of NBCL Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NBCL Pharmaceuticals Private Limited
NBCL Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
NBCL Pharmaceuticals was a private limited company based in Nagpur, Maharashtra, India. The company worked in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 10 August 2016 and is registered under CIN U24110MH2016PTC284668. The company has been struck off by the Registrar of Companies and is no longer operational.
NBCL Pharmaceuticals had 2 directors:
- Chandir Chimandas Ramani - Director
- Babita Chandir Ramani - Director
The CIN (Corporate Identification Number) of NBCL Pharmaceuticals is U24110MH2016PTC284668. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of NBCL Pharmaceuticals is at House No. 91 Besides Nikalas Mandir Bhaji Mandi, Nagpur, Maharashtra, India – 440002.
NBCL Pharmaceuticals was incorporated on 10 August 2016. It is registered with the Registrar of Companies, Mumbai.
NBCL Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
NBCL Pharmaceuticals operated in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment. It worked in this industry before it was struck off.
No. NBCL Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.
Ritesh Chimandas Ramani ceased to be Director on 21 Nov 2016. Vinod Chimandas Ramani ceased to be Director on 21 Nov 2016. Babita Chandir Ramani was appointed as Director on 18 Nov 2016. NBCL Pharmaceuticals has 4 board changes on record in total.